EUVIMEDEUVIMED entdecken
Open Access

Recombinant outer membrane vesicles delivering eukaryotic expression plasmid of cytokines act as enhanced adjuvants against Helicobacter pylori infection in mice

Qiong Liu iD, Biaoxian Li, Jiahui Lu, Yejia Zhang, Yinpan Shang, Yi Li, Tian Gong, Chengsheng Zhang

Infection and Immunity · 16.11.2023 · 91 (11)

DOI: 10.1128/iai.00313-23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Infection and Immunity, erschienen am 16.11.2023. Verfasst von Qiong Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center for Molecular Diagnosis and Precision Medicine, and The Department of Clinical Laboratory, The First Affiliated Hospital of Nanchang Universit…. Hauptthemen laut MEDLINE: Helicobacter pylori, Helicobacter Infections, Vaccines. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Project for high and talent of Science and Technology Innovation in Jiangxi, MOST | National Natural Science Foundation of China (NSFC), Training Plan for Academic and Technical Leaders of Major Disciplines in Jiangxi Province-Youth Talent Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The widespread prevalence of Helicobacter pylori ( H. pylori ) infection remains a great challenge to human health. The existing vaccines are not ideal for preventing H. pylori infection; thus, exploring highly effective adjuvants may improve the immunoprotective efficacy of H. pylori vaccines. In a previous study, we found that the outer membrane vesicles (OMVs), a type of nanoscale particle spontaneously produced by Gram-negative bacteria, could act as adjuvants to boost the immune responses to vaccine antigens. In this study, we explored the potential application of OMVs as delivery vectors for adjuvant development. We constructed recombinant OMVs containing eukaryotic expression plasmid of cytokines, including interleukin 17A or interferon-γ, and evaluated their function as adjuvants in combination with inactivated whole-cell vaccine (WCV) or UreB as vaccine antigens. Our results showed that recombinant OMVs as adjuvants could induce stronger humoral and mucosal immune responses in mice than wild-type H. pylori OMVs and the cholera toxin (CT) adjuvant. Additionally, the recombinant OMVs significantly promoted Th1/Th2/Th17-type immune responses. Furthermore, the recombinant OMV adjuvant induced more potent clearance of H. pylori than CT and wild-type OMVs. Our findings suggest that the recombinant OMVs coupled with cytokines may become potent adjuvants for the development of novel and effective vaccines against H. pylori infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Helicobacter pyloriHelicobacter InfectionsVaccinesHumansAnimalsMiceCytokinesAdjuvants, ImmunologicCholera ToxinPlasmidsBacterial VaccinesAntibodies, Bacterial

Stichwörter der Autor:innen

Helicobacter pyloriadjuvantdelivery vectorrecombinant OMVsvaccine

Substanzen

CytokinesAdjuvants, ImmunologicCholera ToxinVaccinesBacterial VaccinesAntibodies, Bacterial

Autor:innen und Institutionen

  • Center for Molecular Diagnosis and Precision Medicine, and The Department of Clinical Laboratory, The First Affiliated Hospital of Nanchang University , Nanchang, China.
  • The Department of Medical Microbiology, School of Medicine, Nanchang University , Nanchang, China.

ORCID-Profile: Qiong Liu

Förderung

  • Project for high and talent of Science and Technology Innovation in Jiangxi
  • MOST | National Natural Science Foundation of China (NSFC)
  • Training Plan for Academic and Technical Leaders of Major Disciplines in Jiangxi Province-Youth Talent Project
  • Start-up fund from the First Affiliated Hospital of Nanchang University
  • Key Research and Development Projects of Jiangxi Natural Science Foundation

Zitieren

APA

Liu, Q., Li, B., Lu, J., Zhang, Y., Shang, Y., Li, Y., Gong, T., & Zhang, C. (2023). Recombinant outer membrane vesicles delivering eukaryotic expression plasmid of cytokines act as enhanced adjuvants against Helicobacter pylori infection in mice. Infection and Immunity, 91(11). https://doi.org/10.1128/iai.00313-23

Vancouver

Liu Q, Li B, Lu J, Zhang Y, Shang Y, Li Y, et al. Recombinant outer membrane vesicles delivering eukaryotic expression plasmid of cytokines act as enhanced adjuvants against Helicobacter pylori infection in mice. Infection and Immunity. 2023;91(11). doi:10.1128/iai.00313-23

BibTeX
@article{Liu2023,
  author = {Liu, Qiong and Li, Biaoxian and Lu, Jiahui and Zhang, Yejia and Shang, Yinpan and Li, Yi and Gong, Tian and Zhang, Chengsheng},
  title = {Recombinant outer membrane vesicles delivering eukaryotic expression plasmid of cytokines act as enhanced adjuvants against Helicobacter pylori infection in mice},
  journal = {Infection and Immunity},
  year = {2023},
  volume = {91},
  number = {11},
  doi = {10.1128/iai.00313-23}
}
Kostenlos starten →